Supplementary Material and Methods
Part I: Synthesis of the potential TKIs Table S1 . Structures of synthesized compounds. 
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Experimental chemistry methods
All commercial chemicals and solvents used were analytical grade and were used without further purification. Analytical thin layer chromatography (tlc) was performed on pre-coated silica gel plates (Merck 60-F-254, 0.25 mm). Flash chromatography was performed on a Biotage Isolera One using SNAP KP-Sil cartridges, eluting with the solvent specified for individual compounds. Melting points were determined on a Gallenkamp MFB-595-010M
melting point apparatus and are uncorrected. The 1 H-NMR spectra were recorded on a
Bruker 300-AMX spectrometer with TMS as an internal standard. Coupling constants are given in Hz, and the relative area peaks were in agreement with all assignments. Elemental analyses were performed on a Perkin-Elmer 2400 analyzer. Mass spectra were performed on an Applied Biosystem Mariner System 5220 with direct injection of the sample. Microwave assisted reactions were performed on a CEM Discover® monomode reactor with the temperature monitored by a built-in infrared sensor and automatic control of power; all reactions were performed in closed devices with pressure control. Purity for all the tested compounds was determined by elemental analyses and found to be equal to or greater than 95%.
Synthesis of 6-anilino-4-phenylaminopyrimidines 1-7.
Scheme S1. Synthesis of compounds 1-7 and 8-12 Table S1 for R specification.
4-Chloro-6-anilinopyrimidine (29).
A mixture of 28 (1.3 g, 9.0 mmol), aniline (1.0 mL, 9.9 mmol) and TEA (1.4 mL, 18.0 mmol) in i-PrOH (3 mL) was microwave irradiated at 150 °C (power set point 100 W; ramp time 1 min; hold time 30 min). After cooling, the mixture was evaporated under reduced pressure. The residue was diluted with sat. NaHCO 3 solution (20 mL) and the resulting precipitate was collected by filtration to give 29 (1.6 g, 84%); mp:
156°C. 
General procedure for 6-anilino-4-phenylaminopyrimidines 1-6.
A mixture of 29 (0.2 g, 1.0 mmol) and aniline derivative (1.0 mmol) in i-PrOH (3 mL) was microwave irradiated at 150 °C (power set point 200 W; ramp time 1 min; hold time 20 min).
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After cooling, the mixture was poured into sat. NaHCO 3 (20 mL) and the obtained precipitate was collected by filtration. The solid was crystallized to give 1-6. Table S1 for R specification.
4-(3''-Methyl)aniline-6-phenylaminopyrimidine (1)
.
4-Hydroxy-6-phenyl-2-mercaptopyrimidine (31).
To a solution of ethyl benzoylacetate (30) (8.6 mL, 50.0 mmol) in EtOH (30 mL), an EtONa/EtOH 20% solution (20 ml) was added and the mixture was stirred at room temperature for 20 min. Thiourea (4.6 g, 60.0 mmol) was then added, and the mixture was heated at reflux for 24 h. After cooling, the mixture was evaporated under reduced pressure, and the residue was diluted with water (100 mL) and 
4-Hydroxy-6-phenylpyrimidine (32).
To a solution of 31 (4.1 g, 20.0 mmol) in ethanolic NH 4 OH (3:1, 300 mL) an aqueous suspension of Raney-Nickel (8 mL) was added and the mixture was heated at reflux for 6 h. The mixture was evaporated under reduced pressure, and the residue was diluted with water (100 mL) and acidified with conc. HCl to pH = 2. The S12 After cooling, the resulting precipitate was collected by filtration to give 13-17 (as hydrochlorides) and 18. Table S1 for R specification.
4-Chloro
4-(3''-Methyl)anilino-6-phenylpyrimidine hydrochloride (13
4-(3''-Hydroxy)anilino-6-phenylpyrimidine hydrochloride (15
4-(4''-Amino)anilino-6-phenylpyrimidine (18
N,N-Dimethylaminomethylene thiourea (35).
A solution of thiourea (34) 
4-(3''-Methyl)anilino-5-phenylpyrimidine (20
4-(3''-Biphenyl)amino-5-phenylpyrimidine (21
4-(4''-Methyl)anilino-5-phenylpyrimidine (23
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N-phenyl-N'-[4'-(5''-phenylpyrimidin-4''-ylamino)phenyl]urea (26)
4-Chloro-6-(3-nitrophenyl)pyrimidine (45)
4-(4'-
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Part II: Details on ligands hydration procedure
Before docking simulations, the ".pdbqt" file of compounds 19 and 27 were solvated using the python script (wet.py) described by Forli and Olson. 10 The coordinates of the water molecule directed to the 3N of pyrimidine (i.e. the water molecule supposed to mediate the interaction with the threonine gatekeeper) were slightly modified before docking, according to the distances and angle measured in the crystallographic structure of erlotinib in complex with EGFR (PDB ID: 1M17). The results of the modifications are reported in Figure S1 . Figure S3 . Dose/response curve for compound 19 against tested kinases for Kd determination. The amount of kinase measured by qPCR (Signal; y-axis) is plotted against the corresponding compound concentration in nM in log10 scale (x-axis). Data points marked with an "x" were not used for Kd determination. Figure S4 . Dose/response curve for compound 27 against tested kinases for Kd determination. The amount of kinase measured by qPCR (Signal; y-axis) is plotted against the corresponding compound concentration in nM in log10 scale (x-axis). Data points marked with an "x" were not used for Kd determination. tumor inoculation (palpable tumor), tumor-bearing mice were randomized into vehicle control and treatment groups (8 mice per group). Compound 49 was dosed daily at 7.5 mg/kg ip and CDDP was dosed daily at 1.5 mg/kg ip. At day 20, animals were sacrificed (i.e., before tumor can cause the animal discomfort), the legs were amputated at the proximal end of the femur, and the inhibition of tumor growth was determined according to the difference in weight of the tumor-bearing leg and the healthy leg of the animals expressed as % referred to the control animals. Control is constituted by vehicle (0. 
